http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 02 Jun 2026 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Press+Releases/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html <p align="center"><em>In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD </em></p> <p align="center"><em>Company to highlight AXPAXLI™ wet AMD NDA submission plan, updates on SOL-R, SOL-X, and registrational diabetic retinopathy program, and an overview of the planned commercialization approach for AXPAXLI, if approved</em></p> <p align="center"><em>The live event will take place in New York City on June 17, 2026, starting at 2:00 PM ET</em></p> <p>BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) http://www.streetinsider.com/Globe+Newswire/Ocular+Therapeutix%E2%84%A2+to+Host+Investor+Day+on+June+17%2C+2026/26587185.html Tue, 02 Jun 2026 07:00:00 -0400 A.03562356 A.11955935 A.31465178 A.33907774 A.37798023 A.50201488 A.60012012 A.60012014 A.60012014 O.00064716 O.08185705 O.08429242 O.20394154 O.20847516 O.21047305 O.21247872 O.21533112 O.21924861 O.41188961 OCUL